Quantification of genotype 4 hepatitis C virus RNA by the COBAS ampliprep/COBAS TaqMan hepatitis C virus test

Hepatology

Volumn 50, Issue 5, 2009, Pages 1679-1680

  Germer, Jeffrey J ^a   Bommersbach, Carl E ^a   Schmidt, Dana M ^a   Bendel, Jordan L ^a   Yao, Joseph D C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ANALYTICAL EQUIPMENT; CLINICAL LABORATORY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LETTER; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRUS DETECTION; VIRUS EXAMINATION; VIRUS LOAD; VIRUS MUTATION;

DIAGNOSTIC TESTS, ROUTINE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 72949088204     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23282     Document Type: Letter

References (9)

1. Chevaliez S, Bouvier-Alias M, Castera L, Pawlotsky JM. The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples. HEPATOLOGY 2009;49:1397-1398.
2. Sarrazin C, Dragan A, Gartner BC, Forman MS, Traver S, Zeuzem S, et al. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA. J Clin Virol 2008;43:162-168.
3. Pittaluga F, Allice T, Abate ML, Ciancio A, Cerutti F, Varetto S, et al. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay. J Med Virol 2008;80:254-260.
4. Michelin BD, Muller Z, Stelzl E, Marth E, Kessler HH. Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA. J Clin Virol 2007;38:96-100.
5. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, et al. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2007;38:326-333.
6. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. HEPATOLOGY 2007;46:22-31.
7. Sarrazin C, Gartner BC, Sizmann D, Babiel R, Mihm U, Hofmann WP, et al. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J Clin Microbiol 2006;44:729-737.
8. Tuaillon E, Mondain AM, Ottomani L, Roudiere L, Perney P, Picot MC, et al. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay. J Clin Microbiol 2007;45:3077-3081.
9. Vermehren J, Kau A, Gartner BC, Gobel R, Zeuzem S, Sarrazin C. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification. J Clin Microbiol 2008;46:3880-3891.